Thyrocare Technologies has announced a key leadership appointment with Rajdeep Panwar joining as Chief Commercial Officer. The appointment will be effective from January 05, 2026, marking a strategic addition to the company's senior management team.

Leadership Appointment Details

The new Chief Commercial Officer brings significant industry expertise to Thyrocare Technologies. Key details of the appointment include:

Professional Background

Rajdeep Panwar's appointment comes with substantial industry credentials, having accumulated 21 years of experience specifically in the healthcare and diagnostics sector. This extensive background positions him well to lead Thyrocare's commercial operations and drive business growth initiatives.

Strategic Implications

The appointment of an experienced professional to the Chief Commercial Officer role reflects Thyrocare Technologies' commitment to strengthening its leadership team. With Panwar's two decades of sector-specific experience, the company appears focused on enhancing its commercial strategy and market presence in the diagnostics industry.

This leadership addition comes as part of Thyrocare's ongoing efforts to build a robust management structure capable of navigating the competitive healthcare diagnostics landscape. The timing of the appointment, scheduled for early 2026, suggests strategic planning for the company's future commercial initiatives.

Thyrocare Technologies Limited has announced a key leadership appointment with Dr. Ramesh Kinha joining as Chief Operating Officer, effective December 18, 2025. The appointment represents a strategic move to strengthen the company's operational leadership team with an experienced healthcare and diagnostics professional.

Board Approval and Regulatory Compliance

The Board of Directors approved Dr. Kinha's appointment upon recommendation from the Nomination and Remuneration Committee. The decision was formalized through a circular resolution passed on December 18, 2025 at 10:35 A.M. (IST). The appointment has been disclosed in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Professional Background and Experience

Dr. Ramesh Kinha brings over 17 years of extensive experience in healthcare and diagnostics across reputed organizations. His most recent role was as Group Director Laboratory Services at Vijaya Diagnostic Centre Limited. Throughout his career, he has held significant leadership positions at several prominent healthcare companies:

• Apollo Health Lifestyle Ltd.
• Medall Healthcare Pvt. Ltd.
• Metropolis Healthcare Limited
• SRL Ltd.

Educational Qualifications and Certifications

Dr. Kinha possesses strong academic credentials and professional certifications that align with his healthcare leadership role:

Core Competencies

Dr. Kinha's expertise spans multiple critical areas essential for operational excellence in the diagnostics industry. His competencies include laboratory services management, operations oversight, quality assurance protocols, and strategic leadership. He also brings valuable experience in cross-functional coordination, customer relationship management, and organization-wide strategic initiatives.

Strategic Impact

The appointment of Dr. Kinha as Chief Operating Officer is expected to enhance Thyrocare Technologies' operational capabilities and strategic execution. His extensive background in laboratory services and diagnostics operations positions him well to contribute to the company's continued growth and operational excellence in the healthcare sector.